US EditionPublished • loading... • Updated
Enzene's $50M biopharma plant expands NJ's life sciences sector
Summary by NJBIZ
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Enzene's $50M biopharma plant expands NJ's life sciences sector
The basics: Enzene Biosciences opens first U.S. plant in Hopewell $50M investment will bring 200 biotech manufacturing jobs Facility features EnzeneX continuous biologics technology Gov. Murphy, BioNJ highlight NJ’s life sciences leadership A recent ribbon-cutting event marked a significant moment for the state’s life sciences and innovation sector. Indian biotech company Enzene Biosciences officially began its first foray into the United State…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
